Literature DB >> 6999348

A study of induced hyponatremia in the prevention and treatment of sickle-cell crisis.

R M Rosa, B E Bierer, R Thomas, J S Stoff, M Kruskall, S Robinson, H F Bunn, F H Epstein.   

Abstract

Because the formation of sickle cells is dependent on the intracellular concentration of deoxyhemoglobin S, we investigated the possibility of altering or preventing sickle-cell crises by reducing serum sodium so as to cause red cells to swell. In three patients with sickle-cell anemia who had been disabled by recurrent painful crises, sustained dilutional hyponatremia was induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in combination with a high fluid intake. Mean corpuscular hemoglobin concentration fell, and the degree of sickling at low partial oxygen pressure was reduced, as determined by morphologic criteria and by increased oxygen affinity of blood. Chronic hyponatremia (serum sodium, 120 to 125 mmol per liter) reduced the frequency of painful crises, whereas acutely induced hyponatremia abbreviated the duration of crises. These results, although preliminary, are encouraging enough to warrant further study of the safety and effectiveness of induced hyponatremia in the prevention and treatment of sickle-cell crises.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999348     DOI: 10.1056/NEJM198011133032002

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

Review 1.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

2.  Sodium-potassium pump, ion fluxes, and cellular dehydration in sickle cell anemia.

Authors:  H Izumo; S Lear; M Williams; R Rosa; F H Epstein
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 3.  Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.

Authors:  Uduak Okomo; Martin M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

Review 4.  Treating sickle cell disease by targeting HbS polymerization.

Authors:  William A Eaton; H Franklin Bunn
Journal:  Blood       Date:  2017-04-06       Impact factor: 22.113

Review 5.  Disorders of erythrocyte hydration.

Authors:  Patrick G Gallagher
Journal:  Blood       Date:  2017-10-19       Impact factor: 22.113

6.  Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.

Authors:  C Brugnara; L de Franceschi; S L Alper
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Effect of cetiedil on cation and water movements in erythrocytes.

Authors:  W F Schmidt; T Asakura; E Schwartz
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

8.  Bone infarction in children with sickle cell disease: early diagnosis and differentiation from osteomyelitis.

Authors:  A Koren; I Garty; E Katzuni
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

9.  Inhibition of K+ efflux and dehydration of sickle cells by [(dihydroindenyl)oxy]alkanoic acid: an inhibitor of the K+ Cl- cotransport system.

Authors:  D Vitoux; O Olivieri; R P Garay; E J Cragoe; F Galacteros; Y Beuzard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  Shape change of sickled erythrocytes induced by pulsed rf electrical fields.

Authors:  S Takashima; S Chang; T Asakura
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.